Manufacturing adherent cells, such as pluripotent stem cells (PSC) and their derivatives or mesenchymal stromal cells (MSC), to GMP standards is a challenging endeavor. It involves many open handling steps and requires multiple devices, high-class cleanrooms, and well-trained operators, which can compromise reproducibility and significantly increase manufacturing costs. Relying on our widely used CliniMACS Prodigy® Cell Manufacturing Platform, we have developed the Adherent Cell Culture System. It automates GMP-compliant stem cell expansion and differentiation processes in a closed and scalable system.
In this virtual demo, you will learn:
Chao performed his PhD projects at the Chinese Academy of Sciences in Beijing, China, and then continued his Postdoc studies at the University of Bonn and the German Center for Neurodegenerative Diseases in Bonn, Germany, focusing on cell fate (re)programming. Chao joined Miltenyi Biotec as a Product Manager for the Regenerative Medicine portfolio in 2018. He and his colleagues are developing automated, closed, and scalable adherent stem cell cultivation technologies based on the widely used CliniMACS Prodigy® Cell Manufacturing Platform.
Access online courses anytime, anywhere.
Become an expert in standard and innovative applications.
Acquire broad expertise and a comprehensive skill set.
Seems like you are coming from USA!
Do you want to visit our website in your country?